1-5 of 5
Authors: Cynthia Donovan
Save search
Sort by
Journal Article

1564. Virological Suppression in People with HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)

PDF
Andrew P Brogan and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1399, https://doi.org/10.1093/ofid/ofad500.1399
Published: 27 November 2023
Journal Article

Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis

PDF
Madhusudan Kabra and others
Open Forum Infectious Diseases, Volume 10, Issue 11, November 2023, ofad526, https://doi.org/10.1093/ofid/ofad526
Published: 27 October 2023
Journal Article

Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review

PDF
Josep M Llibre and others
Open Forum Infectious Diseases, Volume 9, Issue 4, April 2022, ofac068, https://doi.org/10.1093/ofid/ofac068
Published: 10 February 2022
Journal Article

Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study

PDF
Imtiaz Alam and others
Open Forum Infectious Diseases, Volume 4, Issue 1, Winter 2017, ofw258, https://doi.org/10.1093/ofid/ofw258
Published: 26 December 2016
Journal Article

Using Empirical Information in the Era of HIV/AIDS to Inform Mitigation and Rural Development Strategies: Selected Results from African Country Studies Get access

PDF
David Mather and others
American Journal of Agricultural Economics, Volume 87, Issue 5, December 2005, Pages 1289–1297, https://doi.org/10.1111/j.1467-8276.2005.00821.x
Published: 01 December 2005